PPH
VanEck Pharmaceutical ETF
2026-06-05
Closing price:
105.75
Description of PPH
VanEck Pharmaceutical ETF (PPH) seeks to replicate as closely as possible, before fees and expenses, the price and yield performance of the MVIS US Listed Pharmaceutical 25 Index. The fund normally invests at least 80% of its total assets in securities that comprise the fund's benchmark index. The index includes common stocks and depositary receipts of U.S. exchange-listed companies in the pharmaceutical industry. Such companies may include medium-capitalization companies and foreign companies that are listed on a U.S. exchange.
Use PPH Preset Filters, or set your own Custom Filters, to screen for peers and compare PPH against filtered results:
Please allow some time for the page to load. Refresh the page in case some tables / charts cannot display properly.
PPH Profile vs Filtered Results
Profile of All Filtered Results
| Code | ETF Name | Fund Size (USD) | Expense Ratio % | Dividend Yield % |
|---|---|---|---|---|
As of 2026-06-05
PPH Performance vs Filtered Results
Return vs
PPH Percentile vs Filtered Results
Metrics of All Filtered Results
As of 2026-06-05
Returns are total returns with dividends reinvested.
Returns are total returns with dividends reinvested.
PPH Performance vs Filtered Results
PPH Percentile vs Filtered Results
Return of All Filtered Results
As of 2026-06-05
Returns are total returns with dividends reinvested.
Returns are total returns with dividends reinvested.